Norgine invests £23 million in Wales site to modernize production and boost resilience for UK and European medicine supply chains.

Upperton Pharma Solutions submits MHRA application for a new Annex 1–compliant sterile manufacturing facility, expanding clinical-scale CDMO capacity for biotech and pharma companies.

ZIBO CITY, SHANDONG PROVINCE, CHINA, March 5, 2026 /EINPresswire.com/ -- The global veterinary pharmaceuticals market ...

In the current global industrial landscape, characterized by fluctuating raw material prices and tightening environmental ...

WENZHOU, ZHEJIANG, CHINA, March 2, 2026 /EINPresswire.com/ — In the contemporary landscape of industrial ...

Introduction to AuditsIn the fields of pharmaceuticals and medical devices where regulation is imposed, compliance with the quality standards set by the authorities is vital for the protection of the ...

Outlining four developments set to change how life-sciences organizations design, deploy, and govern intelligent systems in the year ahead.

BRAVO is a portable Raman spectrometer designed for rapid identification and authentication of raw materials. It delivers ...

KIMA CHEMICAL CO., LTD, a prominent global entity in the cellulose derivative sector, has formally announced the successful alignment of its production frameworks with international quality benchmarks ...

Global Industry Trends and the Cellulose Ether Market Outlook The global market for Sodium Carboxymethyl Cellulose is ...

Fc receptors function as the essential bridge between the innate and adaptive immune systems. When antibodies bind to their ...

Major biotech and pharmaceutical companies are asking the Trump administration to rescind two proposals seeking to align US ...